CoreWeave (CRWV) stock today: Credit agreement amendment puts liquidity covenant in focus after Friday surge
4 January 2026
2 mins read

CoreWeave (CRWV) stock today: Credit agreement amendment puts liquidity covenant in focus after Friday surge

NEW YORK, January 3, 2026, 20:10 ET — Market closed

  • CoreWeave disclosed an amendment to its DDTL 3.0 credit agreement, easing minimum liquidity and delaying some covenant tests. 1
  • Shares last closed up 10.77% at $79.32 on Friday, after trading between $73.16 and $81.17. 2
  • Next catalysts include the amendment exhibit in the coming Form 10-K and an estimated Feb. 9 earnings window on Nasdaq’s calendar. 3

CoreWeave, Inc. said it amended a credit agreement tied to its DDTL 3.0 facility, a regulatory filing showed. 1

Shares of the AI cloud provider closed Friday up 10.77% at $79.32, data showed. 2

The amendment lands as investors weigh how quickly debt-heavy AI infrastructure companies can keep adding capacity without tripping lender safeguards. Covenants — rules inside loan documents that require cash levels or financial ratios — can force a borrower to raise funding or curb spending if it falls short.

DDTL stands for delayed-draw term loan, which lets a borrower take down funding over time rather than all at once. CoreWeave said the change was meant to align the facility with the timing of deliveries discussed on its earnings call for the quarter ended Sept. 30, 2025. 3

The amendment, signed on Dec. 31, changes the DDTL 3.0 credit agreement originally dated July 28, 2025, with MUFG Bank as administrative agent and U.S. Bank among the counterparties, the filing said. It cuts the minimum liquidity amount (cash and other readily available funds) for monthly payment dates ending on and after March 1, 2026 and prior to May 1, 2026 to $100 million, and postpones the first tests of the debt service coverage ratio — a cashflow-to-debt-payment metric — until Oct. 31, 2027 and the contract realization ratio until Feb. 28, 2026. CoreWeave said it can use an unlimited number of “equity cures” — equity injections to remedy a covenant breach — until Oct. 28, 2026, subject to limits after that. 4

Broader U.S. equities were mixed on Friday, with the Nasdaq easing while the S&P 500 and Dow finished higher as traders watched bond yields and the Federal Reserve outlook. CoreWeave outperformed that tape.

CoreWeave has leaned on capital markets to fund rapid buildouts of AI data-center capacity. In December it priced an upsized $2.25 billion offering of 1.75% convertible senior notes due 2031, according to a company statement. Convertible notes are debt that can convert into shares, potentially diluting existing holders. 5

Debt has become a flashpoint for skeptics. “They have to keep borrowing more and more because they spend more money than they can get,” D.A. Davidson analyst Gil Luria told The Verge. 6

CoreWeave trimmed its annual revenue forecast in November after data center partner delays, Reuters reported, sharpening investor focus on delivery schedules and financing needs.

Before the next session, investors will look for the full amendment text in CoreWeave’s annual report, which the company said would include it as an exhibit. Nasdaq’s earnings calendar listed Feb. 9 as an estimated report date, though companies often confirm dates closer to the release. 3

Technicians will watch whether the stock can hold Friday’s breakout above the prior close around $71.61. The shares traded between $73.16 and $81.17 and changed hands in a volume of about 30 million shares. 7

Macro data could set the tone for high-growth AI names next week, with investors watching the U.S. jobs report due on Jan. 9 for clues on rates and risk appetite, a Reuters column said.

For CoreWeave, the immediate question is whether covenant breathing room and delivery timing translate into steadier cash metrics once markets reopen. Any further funding moves or customer capacity updates are likely to keep the stock volatile.

Stock Market Today

Alphabet stock drops for a fourth straight day as AI spending jitters linger

Alphabet stock drops for a fourth straight day as AI spending jitters linger

7 February 2026
Alphabet shares fell 2.53% to $322.86 Friday, marking a fourth straight decline as investors questioned heavy AI-related spending. The Nasdaq slipped Thursday after Alphabet detailed up to $185 billion in capex, while the Dow and S&P 500 rose Friday on chipmaker gains. U.S. markets reopen Monday, with attention on Alphabet’s outlook and upcoming jobs and inflation data.
BBAI stock jumps 16% into BigBear.ai share-vote week — what to watch next

BBAI stock jumps 16% into BigBear.ai share-vote week — what to watch next

7 February 2026
BigBear.ai Holdings shares surged 15.7% Friday to $4.72 ahead of a key shareholder vote on doubling authorized shares to 1 billion. Options trading was heavy, with a put/call ratio of 0.19. The company recently announced deals in AI customs technology and a partnership with Abu Dhabi’s AD Ports Group. The special meeting is set for Feb. 18, with online voting open until late Feb. 17.
American Airlines stock jumps nearly 8% as airlines rally — what to watch next week

American Airlines stock jumps nearly 8% as airlines rally — what to watch next week

7 February 2026
American Airlines shares jumped 7.6% to $15.24 Friday, rebounding with a broad rally that sent the Dow past 50,000 for the first time. Investors are watching the carrier’s battle with United at Chicago O’Hare, where a summer capacity surge could trigger a fare war. American also announced new Philadelphia–Porto service for 2027 and launched a centennial inflight menu.
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus
Previous Story

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Liquidia (LQDA) stock slides after heavy $30 put bets—what investors are watching next
Next Story

Liquidia (LQDA) stock slides after heavy $30 put bets—what investors are watching next

Go toTop